Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy and Safety Study of Esomeprazole 20mg qd vs Ranitidine 150mg Bid in Patients With an NSAID-Induced Gastric Ulcer
This study has been completed.
Study NCT00401752.   Last updated on March 11, 2009.
Information provided by AstraZeneca
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Gastric Ulcer
Additional conditions recognized in this trial
Stomach Ulcer
Ulcer
More general conditions related to this trial
Digestive System Diseases
Gastrointestinal Diseases
Pathologic Processes
Peptic Ulcer
Stomach Diseases
Interventions listed in this trial
Esomeprazole
Ranitidine
Additional drug interventions recognized in this trial
Anti-Inflammatory Agents, Non-Steroidal
Omeprazole
Ranitidine bismuth citrate
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Inflammatory Agents
Anti-Ulcer Agents
Antirheumatic Agents
Enzyme Inhibitors
Gastrointestinal Agents
Histamine Agents
Histamine Antagonists
Histamine H2 Antagonists
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
AstraZeneca


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services